Pfizer And BioNTech Intend To Initiate First Clinical Trials Of Coronavirus Vaccine As Early As Apr. 2020; BioNTech To Receive $185M Upfront And Is Eligible For Up To $563M In Milestones
Benzinga Newsdesk